SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-14-081265
Filing Date
2014-03-04
Accepted
2014-03-04 06:08:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d687392ds3.htm S-3 213511
2 EX-4.4 d687392dex44.htm EX-4.4 97526
3 EX-5.1 d687392dex51.htm EX-5.1 16561
4 EX-23.1 d687392dex231.htm EX-23.1 1484
5 GRAPHIC g687392g50p51.jpg GRAPHIC 2961
6 GRAPHIC g687392g71t14.jpg GRAPHIC 14752
  Complete submission text file 0001193125-14-081265.txt   354776
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-194293 | Film No.: 14662531
SIC: 2834 Pharmaceutical Preparations